An Investigator Initiated Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants with Treatment Refractory Progressive Multiple Sclerosis (S3.002)
Year: 2025
Type: article
Source: Neurology
Authors: Sasha Gupta, Madhav Seshadri, Robin Lincoln, Naomi Okinishi, Nancy Shum, Samantha Shenoy, Jenai Wilmoth, Stephen Hauser, Bruce Cree
Institution: University of California, San Francisco
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409228242